ResMed | RMD - Interest Expense On Debt



ResMed reported $-5757000 in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Ansell USD 5.6M 4.8M Jun/2024
AtriCure USD 1.35M 79K Jun/2025
Baxter International USD 81M 19M Mar/2025
Cochlear AUD 5.7M 800K Dec/2024
Cooper Companies USD 25.4M 1.2M Jul/2025
CSL USD 240M 18M Dec/2024
Dexcom USD 4.7M 0 Jun/2025
Edwards Lifesciences 15.5M 1000K Jun/2024
Fisher Paykel Healthcare NZD 3.1M 1.8M Mar/2025
Globus Medical 4K 9K Jun/2025
Haemonetics USD 6.96M 1.36M Sep/2024
Hologic USD 28.9M 200K Jun/2025
Idexx Laboratories USD 11.32M 3.66M Jun/2025
Insulet USD 9.5M 8.3M Jun/2025
Integra LifeSciences USD 21.04M 2.23M Jun/2025
Intuitive Surgical 74.9M 18.8M Dec/2024
Masimo USD 8.2M 600K Jun/2025
Medtronic USD 176M 2M Jul/2025
Philips 80M 24M Jun/2025
Ramsay Health Care AUD 305.7M 700K Dec/2024
ResMed USD -5757000 6.53M Jun/2025
Sigma Healthcare AUD 7.97M 365K Jan/2024
Sonic Healthcare AUD 86.91M 43.94M Dec/2024
Steris USD 15.9M 1.21M Jun/2025
Teleflex USD 21.71M 3.16M Jun/2025
Thermo Fisher Scientific USD 404M 101M Jun/2025